Strictly Pharmaceuticals ApS: Financial statements 2022
CVR: 42088838
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
Strictly Pharmaceuticals ApS (CVR 42088838) has filed annual accounts for 2022. In 2022, the company reported a net result of DKK -681. Equity in the 2022 report amounted to DKK 5,976. The solvency ratio was 100%.
- Profit/Loss
- DKK -681
- Equity
- DKK 5,976
- Total Assets
- DKK 5,976
Official annual report
Keep an eye on Strictly Pharmaceuticals ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of March 1, 2022, Søren Wonsild Glud is registered as liquidator of Strictly Pharmaceuticals ApS.
As of March 1, 2022, Søren Wonsild Glud has stepped down as director of Strictly Pharmaceuticals ApS.
On March 1, 2022, Strictly Pharmaceuticals ApS entered liquidation.
Strictly Pharmaceuticals ApS has published its interim report for the period January 31, 2021 – September 30, 2021.
About Strictly Pharmaceuticals ApS
Strictly Pharmaceuticals ApS was a Danish company of the type Anpartsselskab based in Farum, founded in 2021. The company has been dissolved on 15 February 2023. The company was registered under the industry Investeringsselskaber. In 2022, the company reported a net result of DKK -681. Equity in the 2022 report amounted to DKK 5,976.